Nous-209

· Nouscom SRL

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nous-209, covering 2026-02-13 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients [Phase 1, Phase 2]